SALT LAKE CITY, Dec. 1, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN - News) announced today that Mark Capone, President, Myriad Genetic Laboratories, Inc., is scheduled to present at the Oppenheimer Healthcare Conference, at 9:40 a.m. Eastern Time on Wednesday, December 14, 2011. The conference is being held at the Waldorf Astoria Hotel in New York, New York. The presentation will be available to interested parties through a live webcast accessible on the investor relations section of Myriad’s website at www.myriad.com.
